Windhover.com | Medtech Insight | The RPM Report | Inteleos | EBI
Subscriber Username:   Password: Forgot Password?
Health Care Business Intelligence, Analysis, Insight - Windhover
Search


Receive Windhover's unique market insight fast with our free alert service 'Windhover's Update', including the latest abstracts and summaries from:

• IN VIVO
• Start-Up
• The RPM Report
• Medtech Insight


Sign up now

Reprints, Electronic Licenses, Distribution Rights and Academic Use



Print and electronic reprints from Windhover Information are available for purchase to complement your marketing efforts. Windhover’s expert, in-depth editorial content provides an objective perspective regarding your products, services and company to investors, shareholders, potential partners and others.

Ideal for use with…
- Trade Shows, Conferences and Seminars
- Customer Communications
- Public Relations
- Media Kits
- Education and Training Programs
- Web Content
- Investor Relations
- E-marketing


Product Offerings

  • Print Reprints
    Optional customization available.
  • Online Article Licensing
    Permission to post PDF of article for online use.
    Rates available for 6-months, 12-months and unlimited use.
  • E-Prints – Permission to email PDF of article
    Rates based on number of emails sent.
  • Intranet Article Licensing
    Unlimited use available for internal client use only.
  • Academic Rates Available

To obtain a price quote and/or additional product information - please contact:

Pat Cardone
Phone: (203) 838-4401 x124
Email: p.cardone@elsevier.com


The IN VIVO Blog

Pharmaceutical Strategic Alliances
September 21-23, 2010 · New York, NY

PharmAsia Summit
October 25-26, 2010 · San Francisco, CA

IN3 Summit
October 27-29, 2010 · San Francisco, CA

Interested in presenting at a Windhover conference?
Submit your idea here


Novartis Follows Its Own Business Development Model into Molecular Diagnostics
Novartis is mirroring its approach to pharma R&D and leveraging the byproducts of its biomarker work there to build a commercial molecular diagnostics franchise. The head of the unit talks about its structure, strategy and programs. . . [MORE] (IN VIVO)

Bioactive Technologies For Bone Replacement
Expanded indications for bone morphogenetic proteins and new alternatives to those first-generation bone growth factors have the potential to grow the $2 billion market for bone replacement materials. . . [MORE] (Start-Up)

Laser Cataract Surgery Comes into Focus at ASCRS
The mood was primarily upbeat at April's annual meeting of the American Society of Cataract and Refractive Surgery. Most in attendance expected a modest rebound in procedure volumes for 2010. . . [MORE] (Medtech Insight)

FDA, Drug Development and Health Care Reform: A Panel Discussion
Current and former FDA officials and a former Big Pharma head of R&D discuss FDA and the relationship between a regulator and the industry it regulates when it comes to drug development. . . [MORE] (The RPM Report)

Read more from the latest: IN VIVO, Start-Up, The RPM Report, Medtech Insight, "The Pink Sheet", "The Pink Sheet" DAILY, "The Rose Sheet", "The Tan Sheet", PharmAsia News, Pharmaceutical Approvals Monthly, and "The Gray Sheet".




Pharma Deals
  FDA Has Full Plate This Fall for Vaccines: More Than H1N1
  GSK Slides Away From Innovation
  The Billion Dollar REMS: Xenazine?
Device Deals
  Stroke Devices: Facing Challenges Head On
  Vascular Closure Devices at the Crossroads
  What New Her2 Tests Say about Personalized Medicine

Interested in subscribing? Click here.
Publications - Databases - Conferences - Webinars - About Us - Contact Us - Help - The IN VIVO Blog - RSS Feeds - Company Profiles - Subscriber Login

Copyright © 2010, Windhover Information, Inc. An Elsevier company. All rights reserved.

Elsevier Business Intelligence